WASHINGTON (AP) — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press reported. This decision is expected to have a significant impact on the classification of cannabis and its use in the medical field.
The US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis in a move that is anticipated to have a far-reaching impact on drug policy and public health. Currently, marijuana is classified alongside drugs like heroin and LSD, but this decision will likely place it in a less dangerous category.
The U.S. Drug Enforcement Administration (DEA) has reached an agreement with the Department of Health and Human Services (HHS) to reclassify marijuana, marking a major shift in drug policy. This move comes after years of advocacy from cannabis advocates and medical professionals who believe in the therapeutic benefits of cannabis.
Schumer on SAFER Banking; DEA & FDA at marijuana meeting; FL gov trashes ballot measure; NC medical cannabis deal; NH legalization. These headlines reflect the ongoing discussions and debates surrounding the rescheduling of cannabis by the DEA, showcasing the diverse reactions and opinions on this issue.
The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug as soon as Tuesday, CBS News has learned. This decision comes after years of pressure from advocates and lawmakers who have been pushing for a change in the classification of cannabis.
Cannabis is currently classified along with drugs like heroin and LSD. The administration is expected to reschedule it in a category that reflects its medicinal properties and potential benefits. This move is seen as a step towards broader acceptance and recognition of cannabis as a legitimate medical treatment.
A coalition of Democrats called on the Drug Enforcement Administration (DEA) to quickly remove marijuana from Schedule I of the Controlled Substances Act. This push for rescheduling reflects a growing consensus among policymakers and experts that cannabis should not be treated as a dangerous drug.
The measure, if enacted, would not instantly legalize marijuana at the federal level but could broaden access to the drug for medicinal use. This change in classification could pave the way for more research and studies into the therapeutic effects of cannabis, opening up new possibilities for patients seeking alternative treatments.
Cannabis advocates in Colorado commended the Biden Administration Tuesday on news that the U.S. Drug Enforcement Administration is preparing to reschedule marijuana. This move is seen as a positive step towards recognizing the medical benefits of cannabis and ensuring that patients have access to safe and effective treatment options.
